Skip to main content
Top
Published in: World Journal of Urology 4/2019

01-04-2019 | Uninvited Review

Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis

Authors: Jack Crozier, Nathan Papa, Marlon Perera, Brian Ngo, Damien Bolton, Shomik Sengupta, Nathan Lawrentschuk

Published in: World Journal of Urology | Issue 4/2019

Login to get access

Abstract

Purpose

The detection of lymph node metastases in bladder cancer has a significant impact on treatment decisions. Multiple imaging modalities are available to clinicians including magnetic resonance imaging, computed tomography and positron emission tomography. We aimed to investigate the utility of alternate imaging modalities on pre-cystectomy imaging in bladder cancer for the detection of lymph node metastases.

Methods

We performed systematic search of Web of Science (including MEDLINE), EMBASE and Cochrane libraries in accordance with the PRISMA statement. Studies comparing lymph node imaging findings with final histopathology were included in our analysis. Sensitivity and specificity data were quantified using patient-based analysis. A true positive was defined as a node-positive patient on imaging and node positive on histopathology. Meta-analysis of studies was performed using a mixed-effects, hierarchical logistic regression model.

Results

Our systematic search identified 35 articles suitable for inclusion. MRI and PET have a higher sensitivity than CT while the specificity of all modalities was similar. The summary MRI sensitivity = 0.60 (95% CI 0.44–0.74) and specificity = 0.91 (95% CI 0.82–0.96). Summary PET/CT sensitivity = 0.56 (95% CI 0.49–0.63) and specificity = 0.92 (95% CI 0.86–0.95). Summary CT sensitivity = 0.40 (95% CI 0.33–0.49) and specificity = 0.92 (95% CI 0.86–0.95).

Conclusion

MRI and PET/CT provides superior sensitivity compared to CT for detection of positive lymph nodes in bladder cancer prior to cystectomy. There is variability in the accuracy that current imaging modalities achieve across different studies. A number of other factors impact on detection accuracy and these must be considered.
Literature
1.
go back to reference Alfred Witjes J, Lebret T, Comperat EM, Cowan NC, De Santis M, Bruins HM, Hernandez V, Espinos EL, Dunn J, Rouanne M, Neuzillet Y, Veskimae E, van der Heijden AG, Gakis G, Ribal MJ (2017) Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 71(3):462–475CrossRefPubMed Alfred Witjes J, Lebret T, Comperat EM, Cowan NC, De Santis M, Bruins HM, Hernandez V, Espinos EL, Dunn J, Rouanne M, Neuzillet Y, Veskimae E, van der Heijden AG, Gakis G, Ribal MJ (2017) Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 71(3):462–475CrossRefPubMed
2.
go back to reference Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19(3):666–675CrossRefPubMed Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19(3):666–675CrossRefPubMed
3.
go back to reference Gschwend JDP, Fair W (2002) Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 41:440–448CrossRefPubMed Gschwend JDP, Fair W (2002) Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 41:440–448CrossRefPubMed
4.
go back to reference Zehnder P, Studer UE, Skinner EC, Dorin RP, Cai J, Roth B, Miranda G, Birkhauser F, Stein J, Burkhard FC, Daneshmand S, Thalmann GN, Gill IS, Skinner DG (2011) Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol 186(4):1261–1268CrossRefPubMed Zehnder P, Studer UE, Skinner EC, Dorin RP, Cai J, Roth B, Miranda G, Birkhauser F, Stein J, Burkhard FC, Daneshmand S, Thalmann GN, Gill IS, Skinner DG (2011) Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol 186(4):1261–1268CrossRefPubMed
5.
go back to reference Yang Z, Cheng J, Pan L, Hu S, Xu J, Zhang Y, Wang M, Zhang J, Ye D, Zhang Y (2012) Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer? Ann Nucl Med 26(7):571–577CrossRefPubMed Yang Z, Cheng J, Pan L, Hu S, Xu J, Zhang Y, Wang M, Zhang J, Ye D, Zhang Y (2012) Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer? Ann Nucl Med 26(7):571–577CrossRefPubMed
6.
go back to reference Maurer T, Souvatzoglou M, Kubler H, Opercan K, Schmidt S, Herrmann K, Stollfuss J, Weirich G, Haller B, Gschwend JE, Schwaiger M, Krause BJ, Treiber U (2012) Diagnostic efficacy of 11C-choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy. Eur Urol 61(5):1031–1038CrossRefPubMed Maurer T, Souvatzoglou M, Kubler H, Opercan K, Schmidt S, Herrmann K, Stollfuss J, Weirich G, Haller B, Gschwend JE, Schwaiger M, Krause BJ, Treiber U (2012) Diagnostic efficacy of 11C-choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy. Eur Urol 61(5):1031–1038CrossRefPubMed
7.
go back to reference Thoeny HC, Triantafyllou M, Birkhaeuser FD, Froehlich JM, Tshering DW, Binser T, Fleischmann A, Vermathen P, Studer UE (2009) Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 55(4):761–769CrossRefPubMed Thoeny HC, Triantafyllou M, Birkhaeuser FD, Froehlich JM, Tshering DW, Binser T, Fleischmann A, Vermathen P, Studer UE (2009) Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 55(4):761–769CrossRefPubMed
8.
go back to reference Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700CrossRefPubMedPubMedCentral Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700CrossRefPubMedPubMedCentral
9.
go back to reference Higgins JP, Green S (2008) Cochrane handbook for systematic reviews of interventions. Wiley, West Sussex, EnglandCrossRef Higgins JP, Green S (2008) Cochrane handbook for systematic reviews of interventions. Wiley, West Sussex, EnglandCrossRef
10.
go back to reference Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM (2011) QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536CrossRefPubMed Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM (2011) QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536CrossRefPubMed
11.
go back to reference Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA (2007) A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 8(2):239–251CrossRefPubMed Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA (2007) A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 8(2):239–251CrossRefPubMed
12.
go back to reference Aljabery F, Lindblom G, Skoog S, Shabo I, Olsson H, Rosell J, Jahnson S (2015) PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer. BMC Urol 15:87CrossRefPubMedPubMedCentral Aljabery F, Lindblom G, Skoog S, Shabo I, Olsson H, Rosell J, Jahnson S (2015) PET/CT versus conventional CT for detection of lymph node metastases in patients with locally advanced bladder cancer. BMC Urol 15:87CrossRefPubMedPubMedCentral
13.
go back to reference Rais-Bahrami S, Pietryga JA, Nix JW (2016) Contemporary role of advanced imaging for bladder cancer staging. Urol Oncol 34(3):124–133CrossRefPubMed Rais-Bahrami S, Pietryga JA, Nix JW (2016) Contemporary role of advanced imaging for bladder cancer staging. Urol Oncol 34(3):124–133CrossRefPubMed
14.
go back to reference Soubra A, Hayward D, Dahm P, Goldfarb R, Froehlich J, Jha G, Konety BR (2016) The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis. World J Urol 34(9):1229–1237CrossRefPubMed Soubra A, Hayward D, Dahm P, Goldfarb R, Froehlich J, Jha G, Konety BR (2016) The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis. World J Urol 34(9):1229–1237CrossRefPubMed
15.
go back to reference Vargas HA, Akin O, Schoder H, Olgac S, Dalbagni G, Hricak H, Bochner BH (2012) Prospective evaluation of MRI, 11C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer. Eur J Radiol 81(12):4131–4137CrossRefPubMed Vargas HA, Akin O, Schoder H, Olgac S, Dalbagni G, Hricak H, Bochner BH (2012) Prospective evaluation of MRI, 11C-acetate PET/CT and contrast-enhanced CT for staging of bladder cancer. Eur J Radiol 81(12):4131–4137CrossRefPubMed
16.
go back to reference Orevi M, Klein M, Mishani E, Chisin R, Freedman N, Gofrit ON (2012) 11C-acetate PET/CT in bladder urothelial carcinoma: intraindividual comparison with 11C-choline. Clin Nucl Med 37(4):e67–e72CrossRefPubMed Orevi M, Klein M, Mishani E, Chisin R, Freedman N, Gofrit ON (2012) 11C-acetate PET/CT in bladder urothelial carcinoma: intraindividual comparison with 11C-choline. Clin Nucl Med 37(4):e67–e72CrossRefPubMed
17.
go back to reference Ceci F, Bianchi L, Graziani T, Castellucci P, Pultrone C, Eugenio B, Martorana G, Colletti PM, Rubello D, Fanti S, Schiavina R (2015) 11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard. Clin Nucl Med 40(2):e124–e128CrossRefPubMed Ceci F, Bianchi L, Graziani T, Castellucci P, Pultrone C, Eugenio B, Martorana G, Colletti PM, Rubello D, Fanti S, Schiavina R (2015) 11C-choline PET/CT and bladder cancer: lymph node metastasis assessment with pathological specimens as reference standard. Clin Nucl Med 40(2):e124–e128CrossRefPubMed
18.
go back to reference Brunocilla E, Ceci F, Schiavina R, Castellucci P, Maffione AM, Cevenini M, Bianchi L, Borghesi M, Giunchi F, Fiorentino M, Chondrogiannis S, Colletti PM, Fanti S, Martorana G (2014) Diagnostic accuracy of 11C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings. Clin Nucl Med 39(5):e308–e312CrossRefPubMed Brunocilla E, Ceci F, Schiavina R, Castellucci P, Maffione AM, Cevenini M, Bianchi L, Borghesi M, Giunchi F, Fiorentino M, Chondrogiannis S, Colletti PM, Fanti S, Martorana G (2014) Diagnostic accuracy of 11C-choline PET/CT in preoperative lymph node staging of bladder cancer: a systematic comparison with contrast-enhanced CT and histologic findings. Clin Nucl Med 39(5):e308–e312CrossRefPubMed
19.
go back to reference Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, deVere White RW, Sarosdy MF, Wood DP, Raghavan D, Crawford ED (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349(9):859–866CrossRefPubMed Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, deVere White RW, Sarosdy MF, Wood DP, Raghavan D, Crawford ED (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349(9):859–866CrossRefPubMed
20.
go back to reference Burger M, Mulders P, Witjes W (2012) Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire. Eur Urol 61(5):1070–1071CrossRefPubMed Burger M, Mulders P, Witjes W (2012) Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire. Eur Urol 61(5):1070–1071CrossRefPubMed
21.
go back to reference Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM (2017) Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol 198(3):552–559CrossRefPubMedPubMedCentral Chang SS, Bochner BH, Chou R, Dreicer R, Kamat AM, Lerner SP, Lotan Y, Meeks JJ, Michalski JM, Morgan TM, Quale DZ, Rosenberg JE, Zietman AL, Holzbeierlein JM (2017) Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol 198(3):552–559CrossRefPubMedPubMedCentral
22.
go back to reference Amendola MA, Glazer GM, Grossman HB, Aisen AM, Francis IR (1986) Staging of bladder carcinoma: MRI–CT-surgical correlation. Am J Roentgenol 146(6):1179–1183CrossRef Amendola MA, Glazer GM, Grossman HB, Aisen AM, Francis IR (1986) Staging of bladder carcinoma: MRI–CT-surgical correlation. Am J Roentgenol 146(6):1179–1183CrossRef
23.
go back to reference Tritschler S, Mosler C, Tilki D, Buchner A, Stief C, Graser A (2012) Interobserver variability limits exact preoperative staging by computed tomography in bladder cancer. Urology 79(6):1317–1321CrossRefPubMed Tritschler S, Mosler C, Tilki D, Buchner A, Stief C, Graser A (2012) Interobserver variability limits exact preoperative staging by computed tomography in bladder cancer. Urology 79(6):1317–1321CrossRefPubMed
24.
go back to reference Baltaci S, Resorlu B, Yagci C, Turkolmez K, Gogus C, Beduk Y (2008) Computerized tomography for detecting perivesical infiltration and lymph node metastasis in invasive bladder carcinoma. Urol Int 81(4):399–402CrossRefPubMed Baltaci S, Resorlu B, Yagci C, Turkolmez K, Gogus C, Beduk Y (2008) Computerized tomography for detecting perivesical infiltration and lymph node metastasis in invasive bladder carcinoma. Urol Int 81(4):399–402CrossRefPubMed
25.
go back to reference Barentsz JO, Jager G, Mugler JP, Oosterhof G, Peters H, Vanerning L, Ruijs SHJ (1995) Staging urinary-bladder cancer-value of T1-weighted 3-dimensional magnetization prepared-rapid gradient-echo and 2-dimensional spin-echo sequences. Am J Roentgenol 164(1):109–115CrossRef Barentsz JO, Jager G, Mugler JP, Oosterhof G, Peters H, Vanerning L, Ruijs SHJ (1995) Staging urinary-bladder cancer-value of T1-weighted 3-dimensional magnetization prepared-rapid gradient-echo and 2-dimensional spin-echo sequences. Am J Roentgenol 164(1):109–115CrossRef
26.
go back to reference Chakraborty D, Mittal BR, Kashyap R, Mete UK, Narang V, Das A, Bhattacharya A, Khandelwal N, Mandal AK (2014) Role of fluorodeoxyglucose positron emission tomography/computed tomography in diagnostic evaluation of carcinoma urinary bladder: comparison with computed tomography. World J Nucl Med 13(1):34–39CrossRefPubMedPubMedCentral Chakraborty D, Mittal BR, Kashyap R, Mete UK, Narang V, Das A, Bhattacharya A, Khandelwal N, Mandal AK (2014) Role of fluorodeoxyglucose positron emission tomography/computed tomography in diagnostic evaluation of carcinoma urinary bladder: comparison with computed tomography. World J Nucl Med 13(1):34–39CrossRefPubMedPubMedCentral
27.
go back to reference Chen J, Cui Y, Liu L, Li C, Tang Y, Zhou X, Qi L, Zu X (2016) CCR7 as a predictive biomarker associated with computed tomography for the diagnosis of lymph node metastasis in bladder carcinoma. Oncol Lett 11(1):735–740CrossRefPubMed Chen J, Cui Y, Liu L, Li C, Tang Y, Zhou X, Qi L, Zu X (2016) CCR7 as a predictive biomarker associated with computed tomography for the diagnosis of lymph node metastasis in bladder carcinoma. Oncol Lett 11(1):735–740CrossRefPubMed
28.
go back to reference Daneshmand S, Ahmadi H, Huynh LN, Dobos N (2012) Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study. Urology 80(6):1313–1318CrossRefPubMed Daneshmand S, Ahmadi H, Huynh LN, Dobos N (2012) Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study. Urology 80(6):1313–1318CrossRefPubMed
29.
go back to reference Ficarra V, Dalpiaz O, Alrabi N, Novara G, Galfano A, Artibani W (2005) Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int 95(6):786–790CrossRefPubMed Ficarra V, Dalpiaz O, Alrabi N, Novara G, Galfano A, Artibani W (2005) Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int 95(6):786–790CrossRefPubMed
30.
go back to reference Gofrit ON, Mishani E, Orevi M, Klein M, Freedman N, Pode D, Shapiro A, Katz R, Libson E, Chisin R (2006) Contribution of C-11-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma. J Urol 176(3):940–944CrossRefPubMed Gofrit ON, Mishani E, Orevi M, Klein M, Freedman N, Pode D, Shapiro A, Katz R, Libson E, Chisin R (2006) Contribution of C-11-choline positron emission tomography/computerized tomography to preoperative staging of advanced transitional cell carcinoma. J Urol 176(3):940–944CrossRefPubMed
31.
go back to reference Goodfellow H, Viney Z, Hughes P, Rankin S, Rottenberg G, Hughes S, Evison F, Dasgupta P, O’Brien T, Khan MS (2014) Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer. BJU Int 114(3):389–395PubMed Goodfellow H, Viney Z, Hughes P, Rankin S, Rottenberg G, Hughes S, Evison F, Dasgupta P, O’Brien T, Khan MS (2014) Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer. BJU Int 114(3):389–395PubMed
32.
go back to reference Heicappell R, Muller-Mattheis V, Reinhardt M, Vosberg H, Gerharz CD, Muller-Gartner HW, Ackermann R (1999) Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-F-18-2-deoxy-d-glucose. Eur Urol 36(6):582–587CrossRefPubMed Heicappell R, Muller-Mattheis V, Reinhardt M, Vosberg H, Gerharz CD, Muller-Gartner HW, Ackermann R (1999) Staging of pelvic lymph nodes in neoplasms of the bladder and prostate by positron emission tomography with 2-F-18-2-deoxy-d-glucose. Eur Urol 36(6):582–587CrossRefPubMed
33.
go back to reference Hitier-Berthault M, Ansquer C, Branchereau J, Renaudin K, Bodere F, Bouchot O, Rigaud J (2013) F-18-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study. Int J Urol 20(8):788–796CrossRefPubMed Hitier-Berthault M, Ansquer C, Branchereau J, Renaudin K, Bodere F, Bouchot O, Rigaud J (2013) F-18-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: a prospective study. Int J Urol 20(8):788–796CrossRefPubMed
34.
go back to reference Horn T, Zahel T, Adt N, Schmid SC, Heck MM, Thalgott MK, Hatzichristodoulou G, Haller B, Autenrieth M, Kubler HR, Gschwend JE, Holzapfel K, Maurer T (2016) Evaluation of computed tomography for lymph node staging in bladder cancer prior to radical cystectomy. Urol Int 96(1):51–56CrossRefPubMed Horn T, Zahel T, Adt N, Schmid SC, Heck MM, Thalgott MK, Hatzichristodoulou G, Haller B, Autenrieth M, Kubler HR, Gschwend JE, Holzapfel K, Maurer T (2016) Evaluation of computed tomography for lymph node staging in bladder cancer prior to radical cystectomy. Urol Int 96(1):51–56CrossRefPubMed
35.
go back to reference Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K (2011) Preoperative lymph-node staging of invasive urothelial bladder cancer with F-18-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Scand J Urol Nephrol 45(2):122–128CrossRefPubMed Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K (2011) Preoperative lymph-node staging of invasive urothelial bladder cancer with F-18-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Scand J Urol Nephrol 45(2):122–128CrossRefPubMed
36.
go back to reference Jeong IG, Hong S, You D, Hong JH, Ahn H, Kim CS (2015) FDG PET-CT for lymph node staging of bladder cancer: a prospective study of patients with extended pelvic lymphadenectomy. Ann Surg Oncol 22(9):3150–3156CrossRefPubMed Jeong IG, Hong S, You D, Hong JH, Ahn H, Kim CS (2015) FDG PET-CT for lymph node staging of bladder cancer: a prospective study of patients with extended pelvic lymphadenectomy. Ann Surg Oncol 22(9):3150–3156CrossRefPubMed
37.
go back to reference Kibel AS, Dehdashti F, Katz MD, Klim AP, Grubb RL, Humphrey PA, Siegel C, Cao D, Gao F, Siegel BA (2009) Prospective study of [18F] fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol 27(26):4314–4320CrossRefPubMedPubMedCentral Kibel AS, Dehdashti F, Katz MD, Klim AP, Grubb RL, Humphrey PA, Siegel C, Cao D, Gao F, Siegel BA (2009) Prospective study of [18F] fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol 27(26):4314–4320CrossRefPubMedPubMedCentral
38.
go back to reference Li Z, Qi F, Miao J, Zu X, He W, Wang L, Qi L (2010) Vascular endothelial growth Factor-C associated with computed tomography used in the diagnosis of lymph node metastasis of bladder carcinoma. Arch Med Res 41(8):606–610CrossRefPubMed Li Z, Qi F, Miao J, Zu X, He W, Wang L, Qi L (2010) Vascular endothelial growth Factor-C associated with computed tomography used in the diagnosis of lymph node metastasis of bladder carcinoma. Arch Med Res 41(8):606–610CrossRefPubMed
39.
go back to reference Liedberg F, Bendahl PO, Davidsson T, Gudjonsson S, Holmer M, Mansson W, Wallengren NO (2013) Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol. Scand J Urol 47(2):108–112CrossRefPubMed Liedberg F, Bendahl PO, Davidsson T, Gudjonsson S, Holmer M, Mansson W, Wallengren NO (2013) Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol. Scand J Urol 47(2):108–112CrossRefPubMed
40.
go back to reference Lista F, Andres G, Caceres F, Ramon de Fata F, Rodriguez-Barbero JM, Angulo JC (2013) Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy. Actas Urol Esp 37(7):419–424CrossRefPubMed Lista F, Andres G, Caceres F, Ramon de Fata F, Rodriguez-Barbero JM, Angulo JC (2013) Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy. Actas Urol Esp 37(7):419–424CrossRefPubMed
41.
go back to reference Lodde M, Lacombe L, Friede J, Morin F, Saourine A, Fradet Y (2010) Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma. BJU Int 106(5):658–663CrossRefPubMed Lodde M, Lacombe L, Friede J, Morin F, Saourine A, Fradet Y (2010) Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma. BJU Int 106(5):658–663CrossRefPubMed
42.
go back to reference Paik ML, Scolieri MJ, Brown SL, Spirnak JP, Resnick MI (2000) Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol 163(6):1693–1696CrossRefPubMed Paik ML, Scolieri MJ, Brown SL, Spirnak JP, Resnick MI (2000) Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. J Urol 163(6):1693–1696CrossRefPubMed
43.
go back to reference Persad R, Kabala J, Gillatt D, Penry B, Gingell JC, Smith PJB (1993) Magnetic-resonance-imaging in the staging of bladder cancer. Br J Urol 71(5):566–573CrossRefPubMed Persad R, Kabala J, Gillatt D, Penry B, Gingell JC, Smith PJB (1993) Magnetic-resonance-imaging in the staging of bladder cancer. Br J Urol 71(5):566–573CrossRefPubMed
44.
go back to reference Picchio M, Treiber U, Beer AJ, Metz S, Bössner P, Randenborgh H, Paul R, Weirich G, Souvatzoglou M, Hartung R, Schwaiger M, Piert M (2006) Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings. J Nucl Med 47(6):938–944PubMed Picchio M, Treiber U, Beer AJ, Metz S, Bössner P, Randenborgh H, Paul R, Weirich G, Souvatzoglou M, Hartung R, Schwaiger M, Piert M (2006) Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings. J Nucl Med 47(6):938–944PubMed
45.
go back to reference Rouanne M, Girma A, Neuzillet Y, Vilain D, Radulescu C, Letang N, Yonneau L, Herve JM, Botto H, Le Stanc E, Lebret T (2014) Potential impact of F-18-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy. Eur J Surg Oncol 40(12):1724–1730CrossRefPubMed Rouanne M, Girma A, Neuzillet Y, Vilain D, Radulescu C, Letang N, Yonneau L, Herve JM, Botto H, Le Stanc E, Lebret T (2014) Potential impact of F-18-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy. Eur J Surg Oncol 40(12):1724–1730CrossRefPubMed
46.
go back to reference Swinnen G, Maes A, Pottel H, Vanneste A, Billiet I, Lesage K, Werbrouck P (2010) FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer. Eur Urol 57(4):641–647CrossRefPubMed Swinnen G, Maes A, Pottel H, Vanneste A, Billiet I, Lesage K, Werbrouck P (2010) FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer. Eur Urol 57(4):641–647CrossRefPubMed
47.
go back to reference Tritschler S, Mosler C, Straub J, Buchner A, Karl A, Graser A, Stief C, Tilki D (2012) Staging of muscle-invasive bladder cancer: can computerized tomography help us to decide on local treatment? World J Urol 30(6):827–831CrossRefPubMed Tritschler S, Mosler C, Straub J, Buchner A, Karl A, Graser A, Stief C, Tilki D (2012) Staging of muscle-invasive bladder cancer: can computerized tomography help us to decide on local treatment? World J Urol 30(6):827–831CrossRefPubMed
48.
go back to reference Uttam M, Pravin N, Anish B, Nandita K, Arup M (2016) Is F-18 -fluorodeoxyglucose FDG-PET/CT better than ct alone for the preoperative lymph node staging of muscle invasive bladder cancer? Int Braz J Urol 42(2):234–241CrossRefPubMedPubMedCentral Uttam M, Pravin N, Anish B, Nandita K, Arup M (2016) Is F-18 -fluorodeoxyglucose FDG-PET/CT better than ct alone for the preoperative lymph node staging of muscle invasive bladder cancer? Int Braz J Urol 42(2):234–241CrossRefPubMedPubMedCentral
49.
go back to reference Wollin DA, Deng FM, Huang WC, Babb JS, Rosenkrantz AB (2014) Conventional and diffusion-weighted MRI features in diagnosis of metastatic lymphadenopathy in bladder cancer. Can J Urol 21(5):7454–7459PubMed Wollin DA, Deng FM, Huang WC, Babb JS, Rosenkrantz AB (2014) Conventional and diffusion-weighted MRI features in diagnosis of metastatic lymphadenopathy in bladder cancer. Can J Urol 21(5):7454–7459PubMed
Metadata
Title
Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis
Authors
Jack Crozier
Nathan Papa
Marlon Perera
Brian Ngo
Damien Bolton
Shomik Sengupta
Nathan Lawrentschuk
Publication date
01-04-2019
Publisher
Springer Berlin Heidelberg
Published in
World Journal of Urology / Issue 4/2019
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-018-2439-8

Other articles of this Issue 4/2019

World Journal of Urology 4/2019 Go to the issue